Back

Sex-specific guideline target value attainment and prognostic value of low-density lipoprotein cholesterol in tertiary care

31 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Lipoproteins and cardiovascular risk Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Klara Rumora

Cardiovascular Research Institute Basel, Basel (Switzerland)

7 More presentations in this session

Presentation thumbnail
Circulating Amyloid beta 1-40 is independently associated with statin treatment and LDL cholesterol reduction: a prospective cohort study
Doctor E. Aivalioti (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Factors influencing low-density-lipoprotein cholesterol after acute coronary syndrome and effectiveness of intensive teleconsultation monitoring, the teleobjectif cohort study
Doctor A. Lemaitre (Caen, FR)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol, clinical characteristics and mortality in 41.767 patients from LIPIDOGRAM 2004-2015 studies - the factor analysis for mixed data cluster analysis
Professor M. Banach (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Relationship of cumulative low-density lipoprotein cholesterol with atherosclerosis
Doctor T. Yamaji (Hiroshima, JP)
Abstract Slides Video
Presentation thumbnail
Effects of Chios Mastiha essential oil on cholesterol levels of healthy volunteers: a prospective, randomized, placebo-controlled study.
Doctor D. Afendoulis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Lipoproteins and cardiovascular risk

The Event

Event poster

ESC Congress 2024

31 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Sex differences in management of LDL-cholesterol in patients with chronic coronary syndrome
thumbnail
Congress Presentation
Sex differences in atherogenic lipid profile following acute coronary syndrome
thumbnail
Congress Presentation
Exploring residual cardiovascular risk beyond LDL cholesterol in patients with acute destabilisation of known significant atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources